CU Anschutz Reports Phase 2 Down Syndrome Drug Findings
Aurora, Colorado, USA, November 18, 2026 Researchers at the Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 Clinical Trial Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Aurora, Colorado, USA, November 18, 2026 Researchers at the Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz,...
WALTHAM, Mass. — August 25, 2026 Spyre Therapeutics, Inc. announced topline results from the rheumatoid arthritis (RA) sub-study of...
PRINCETON, N.J., August 14, 2026 Bristol Myers Squibb announced that the U.S. Food and Drug Administration has granted accelerated...
WALTHAM, Massachusetts, and HANGZHOU, China, August 13, 2026 Photys Therapeutics, Inc. and Polymed Biopharmaceuticals, Inc. announced the initiation of...
ZUG, Switzerland, June 21, 2026 MoonLake Immunotherapeutics has announced compelling Week 52 results from its Phase 3 VELA clinical...
OAKVILLE, Ontario, June 9, 2026 UCB Canada announced that BIMZELX® (bimekizumab injection) received a positive reimbursement recommendation with conditions...
BRIDGEWATER, N.J., April 7, 2026 Insmed Incorporated has announced that its Phase 2b CEDAR clinical trial evaluating brensocatib in...
Nantes, France | January 29, 2026 — OSE Immunotherapeutics announced the strategic selection of chronic pouchitis and hidradenitis suppurativa...
JENA, Germany, December 11, 2025 — InflaRx N.V. announced that the World Health Organization (WHO) has granted the International...
Incheon, South Korea – October 16, 2025 – CelltrionUSA, a subsidiary of Celltrion Inc., announced that the U.S. Food...
